Neovasc Incorporation - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Neovasc Incorporation Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Neovasc Incorporation Formerly known as Medical Ventures Corp.. The Group's principal activities is to acquire, develop and commercialize medical technologies. The products of the Group include the Neovasc Reducer for refractory angina and PeriPatch surgical tissue. The Neovasc Reducer provides treatment for patients with refractory angina. Refractory angina patients have severe, debilitating chest pain due to insufficient blood supply to the heart muscle that is not amenable to revascularization. PeriPatch is a flexible collagen-tissue patch cut from a uniform area of chemically treated bovine or equine pericardium. It is used for cardiac reconstruction and repair, soft tissue repair and general surgical procedures. On 01-Jul-2008, the Group acquired Neovasc Medical and B-Balloon.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report